These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 12405827)

  • 1. Studies on the mechanism of action of azinomycin B: definition of regioselectivity and sequence selectivity of DNA cross-link formation and clarification of the role of the naphthoate.
    Coleman RS; Perez RJ; Burk CH; Navarro A
    J Am Chem Soc; 2002 Nov; 124(44):13008-17. PubMed ID: 12405827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA cross-linking by azinomycin B: Monte Carlo simulations in the evaluation of sequence selectivity.
    Alcaro S; Ortuso F; Coleman RS
    J Med Chem; 2002 Feb; 45(4):861-70. PubMed ID: 11831897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A molecular model for DNA cross-linking by the antitumor agent azinomycin B.
    Alcaro S; Coleman RS
    J Med Chem; 2000 Jul; 43(15):2783-8. PubMed ID: 10956185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delineating noncovalent interactions between the azinomycins and double-stranded DNA: importance of the naphthalene substitution pattern on interstrand cross-linking efficiency.
    Landreau CA; LePla RC; Shipman M; Slawin AM; Hartley JA
    Org Lett; 2004 Sep; 6(20):3505-7. PubMed ID: 15387534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA binding and alkylation by the "left half" of azinomycin B.
    Zang H; Gates KS
    Biochemistry; 2000 Dec; 39(48):14968-75. PubMed ID: 11101313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the azinomycin naphthoate and central amide in sequence-dependent DNA alkylation and cytotoxicity of epoxide-bearing substructures.
    Coleman RS; Burk CH; Navarro A; Brueggemeier RW; Diaz-Cruz ES
    Org Lett; 2002 Oct; 4(20):3545-8. PubMed ID: 12323065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular modeling of DNA cross-linking analogues based on the azinomycin scaffold.
    Alcaro S; Ortuso F; Coleman RS
    J Chem Inf Model; 2005; 45(3):602-9. PubMed ID: 15921450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of AziR, a resistance protein of the DNA cross-linking agent azinomycin B.
    Foulke-Abel J; Kelly GT; Zhang H; Watanabe CM
    Mol Biosyst; 2011 Sep; 7(9):2563-70. PubMed ID: 21776524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biosynthesis of 3-methoxy-5-methyl naphthoic acid and its incorporation into the antitumor antibiotic azinomycin B.
    Ding W; Deng W; Tang M; Zhang Q; Tang G; Bi Y; Liu W
    Mol Biosyst; 2010 Jun; 6(6):1071-81. PubMed ID: 20485749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Truncated azinomycin analogues intercalate into DNA.
    Casely-Hayford MA; Pors K; Patterson LH; Gerner C; Neidle S; Searcey M
    Bioorg Med Chem Lett; 2005 Feb; 15(3):653-6. PubMed ID: 15664831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Azinomycin inspired bisepoxides: influence of linker structure on in vitro cytotoxicity and DNA interstrand cross-linking.
    LePla RC; Landreau CA; Shipman M; Hartley JA; Jones GD
    Bioorg Med Chem Lett; 2005 Jun; 15(11):2861-4. PubMed ID: 15911269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biosynthetic studies on the azinomycins: the pathway to the naphthoate fragment.
    Corre C; Landreau CA; Shipman M; Lowden PA
    Chem Commun (Camb); 2004 Nov; (22):2600-1. PubMed ID: 15543299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The minor groove covalent reactive drugs anthramycin and (+)-CC-1065 and their interstrand cross-linking derivatives.
    Hurley LH
    IARC Sci Publ; 1994; (125):295-312. PubMed ID: 7806319
    [No Abstract]   [Full Text] [Related]  

  • 14. Design and synthesis of a DNA-crosslinking azinomycin analogue.
    Casely-Hayford MA; Pors K; James CH; Patterson LH; Hartley JA; Searcey M
    Org Biomol Chem; 2005 Oct; 3(19):3585-9. PubMed ID: 16172698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of a novel DNA glycosylase from S. sahachiroi involved in the reduction and repair of azinomycin B induced DNA damage.
    Wang S; Liu K; Xiao L; Yang L; Li H; Zhang F; Lei L; Li S; Feng X; Li A; He J
    Nucleic Acids Res; 2016 Jan; 44(1):187-97. PubMed ID: 26400161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dependence of DNA sequence selectivity and cell cytotoxicity on azinomycin A and B epoxyamide stereochemistry.
    Coleman RS; Woodward RL; Hayes AM; Crane EA; Artese A; Ortuso F; Alcaro S
    Org Lett; 2007 May; 9(10):1891-4. PubMed ID: 17432865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histone H3 and heat shock protein GRP78 are selectively cross-linked to DNA by photoactivated gilvocarcin V in human fibroblasts.
    Matsumoto A; Hanawalt PC
    Cancer Res; 2000 Jul; 60(14):3921-6. PubMed ID: 10919670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequence selectivity of azinomycin B in DNA alkylation and cross-linking: a QM/MM study.
    Senthilnathan D; Kalaiselvan A; Venuvanalingam P
    J Mol Model; 2013 Jan; 19(1):383-90. PubMed ID: 22930355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aminoacetone as the penultimate precursor to the antitumor agent azinomycin A.
    Sharma V; Kelly GT; Foulke-Abel J; Watanabe CM
    Org Lett; 2009 Sep; 11(17):4006-9. PubMed ID: 19663419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitomycin C: small, fast and deadly (but very selective).
    Tomasz M
    Chem Biol; 1995 Sep; 2(9):575-9. PubMed ID: 9383461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.